Cargando…
HER2 gene and protein expression status of breast carcinoma can be reliably tested on a single slide
Human epidermal growth factor receptor 2 (HER2) status in breast carcinomas serves as a predictor of benefit from anti-HER2 therapy. In providing clinicians with the information necessary to decide whether or not to treat with targeted therapy, it might be necessary to choose between methods assessi...
Autores principales: | Chenard, Marie-Pierre, Wissler, Marie-Pierre, Weingertner, Noëlle, Mathelin, Carole, Bellocq, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529453/ https://www.ncbi.nlm.nih.gov/pubmed/25985875 http://dx.doi.org/10.1007/s00428-015-1781-0 |
Ejemplares similares
-
A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
por: Reix, Nathalie, et al.
Publicado: (2016) -
Follicular Lymphomas of Oral Region Treated by Rituximab Monotherapy: About Two Cases
por: Montaner, Sylvain, et al.
Publicado: (2018) -
Cutaneous manifestations in patients with coronavirus disease 2019: clinical and histological findings()()
por: Fattori, Antonin, et al.
Publicado: (2021) -
STARD3: A New Biomarker in HER2-Positive Breast Cancer
por: Lodi, Massimo, et al.
Publicado: (2023) -
First report of granulomatous mastitis associated with Sjögren’s syndrome
por: Letourneux, Christel, et al.
Publicado: (2013)